| Chr | chr6 |
| start | 10429255 |
| end | 10434874 |
| lncRNA name | Linc00518 |
| entrez id | 221718 |
| hgnc id | HGNC:28626 |
| ensg id | ENSG00000183674 |
| refseq id | NR_027793 |
| methods | qRT-PCR, Western blot assays, Luciferase reporter assays, RIP |
| regulated | up-regulated |
| function description | linc00518 expression increased nearly 2 fold and MRP1 level elevated about 2.5 fold in breast cancer tissues as compared to that in adjacent normal tissues. miR-199a inhibitor conferred chemoresistance to ADR, VCR and PTX in MCF-7/ADR cells, and suppressing miR-199a reversed multi-drug susceptibility induced by linc00518 knockdown. Furthermore, linc00518 could act as a molecular sponge of miR-199a to repress MRP1 expression. MRP1 depletion increased the sensitivity of MCF-7/ADR cells to ADR, VCR and PTX, and this effect was attenuated following miR-199a inhibition or linc00518 |
| pubmed id | 30001527 |
| year | 2018 |
| title | Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer. |
| drug | V |
| circulating | X |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China